Health economic evaluation of Human Papillomavirus vaccines in women from Venezuela by a lifetime Markov cohort model.

Ariel Esteban BardachOsvaldo Ulises GarayMaría CalderónAndrés Pichón-RiviéreFederico AugustovskiSebastián García MartíPaula CortiñasMarino GonzalezLaura T NaranjoJorge Alberto GomezJoaquín Enzo Caporale

Published in: BMC public health (2017)

Immunization with the bivalent or quadrivalent HPV vaccines showed to be cost-saving or cost-effective in Venezuela, falling below the threshold of one Gross Domestic Product (GDP) per capita (104,404 VEF) per QALY gained. Deterministic and probabilistic sensitivity analyses confirmed the robustness of these results.

Keyphrases

cervical cancer screening
public health
healthcare
polycystic ovary syndrome
mental health
high grade
pregnancy outcomes
children with cerebral palsy
metabolic syndrome
health promotion
insulin resistance